Aripiprazole

DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Sales Forecast of FDA’s New Drug Approvals of 2017

2017 was a landmark year for the pharmaceutical industries in the US and Europe, with a sharp increa

Pfizer exits China venture with Hisun; FDA mulls more steps to increase generic drug competition

This week in Phispers, we look at the measures US FDA announced last week to increase competition in

Top drugs by sales in 2016: Who sold the blockbuster drugs?

The year 2016 finished with a whimper insofar as mergers and acquisitions (M&As) were concerned.

Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend

In less than three weeks, Donald Trump will assume office as the President of the United States. He

Sanofi’s rough week; Quality snags at Pfizer; FDA warns against commonly used drug

This week, Phispers delves into Pfizer’s acquisition of Medivation and its impact on Sanofi. T

FDA’s Drug Approvals in 2015: Novel Drugs & New Versions of Existing Drugs

Each year, the US Food and Drug Administration (FDA) approve hundreds of new medications. A small su

Next-gen aripiprazole pill that sends messages from the patient’s stomach

Wouldn’t it be great if your medicine could send a signal from your stomach to the clinic that

Will data integrity concerns on clinical trials done at GVK Biosciences go beyond Europe?

 Over 700 commonly used generic medicines were recommended for suspension by the European Medic